Geron to Present at the B. Riley Securities 3rd Annual Virtual Oncology Conference

Rhea-AI Summary

Geron Corporation (Nasdaq: GERN) announced that Dr. John A. Scarlett, Chairman and CEO, will participate in a virtual fireside chat at the B. Riley Securities 3rd Annual Virtual Oncology Conference on January 18 at 1 p.m. ET. A live webcast will be available via the Investor Relations section of Geron's website, with an archived replay accessible for 30 days post-event. Geron is focused on developing therapies for hematologic malignancies, including the first-in-class telomerase inhibitor, imetelstat.

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Geron’s Chairman and Chief Executive Officer, is scheduled to participate in a virtual fireside chat at the B. Riley Securities 3^rd Annual Virtual Oncology Conference on January 18 at 1 p.m. ET.

A live webcast of the presentation will be available through the Investor Relations section of Geron’s website under Events. Following the presentation, the webcast will be archived and available for replay for a period of 30 days.

About Geron

Geron is a late-stage biopharmaceutical company pursuing therapies with the potential to extend and enrich the lives of patients living with hematologic malignancies. Its investigational first-in-class telomerase inhibitor, imetelstat, harnesses Nobel Prize winning science in a treatment that may alter the underlying course of these diseases.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230112005297/en/

Aron Feingold

Investor and Media Relations

investor@geron.com

media@geron.com

Source: Geron Corporation

FAQ

What is Geron Corporation's stock symbol?

Geron Corporation's stock symbol is GERN.

When will John A. Scarlett participate in the B. Riley Securities Conference?

John A. Scarlett will participate in the B. Riley Securities Conference on January 18 at 1 p.m. ET.

Where can I watch the Geron Corporation presentation?

The presentation can be watched live through the Investor Relations section of Geron's website.

What is imetelstat?

Imetelstat is a first-in-class telomerase inhibitor being developed by Geron for hematologic malignancies.

How long will the webcast of the Geron presentation be available?

The webcast will be available for replay for 30 days after the live event.